Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Flanagan

Showing results (71-80 of 840) with videos related to

Pageof 84
Sort By:
Trends in Cancer Research|September 29, 2017
Epigenome-wide association studies for breast cancer risk and risk factorsAnnelie Johansson, James M Flanagan
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|November 13, 2009
Gas flow driven by thermal creep in dusty plasmaT M Flanagan, J Goree
Critical Reviews in Oncology/Hematology|November 12, 2025
Epigenetic mechanisms of PARP inhibitor resistance in ovarian cancer: A systematic review with bioinformatic analysis of clinically actionable genesMuhammad Habiburrahman, James M Flanagan
Genome Biology|July 3, 2007
An epigenetic role for noncoding RNAs and intragenic DNA methylationJames M Flanagan, Laurence Wild
Australian Veterinary Journal|December 1, 1995
The effects of vaccination of Merino ewes with an attenuated Australian bluetongue virus serotype 23 at different stages of gestationM Flanagan, S J Johnson
Blood|October 1, 1996
Macrophage colony-stimulating factor induces substantial osteoclast generation and bone resorption in human bone marrow culturesU Sarma, A M Flanagan
Cancer Prevention Research (Philadelphia, Pa.)|June 12, 2013
Genome-wide hypomethylation and cancer risk--responseKevin Brennan, James M Flanagan
Pathology|November 8, 2017
A diagnostic approach to bone tumoursAdrienne M Flanagan, Daniel Lindsay
Cell Death and Differentiation|December 18, 2007
BH3 domains define selective inhibitory interactions with BHRF-1 and KSHV BCL-2A M Flanagan, A Letai
British Journal of Cancer|December 15, 2011
Intragenic DNA methylation: implications of this epigenetic mechanism for cancer researchN Shenker, J M Flanagan
Pageof 84

Showing results (71-80 of 840) with videos related to

Sort By:
Pageof 84
Trends in Cancer Research|September 29, 2017
Epigenome-wide association studies for breast cancer risk and risk factorsAnnelie Johansson, James M Flanagan
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|November 13, 2009
Gas flow driven by thermal creep in dusty plasmaT M Flanagan, J Goree
Critical Reviews in Oncology/Hematology|November 12, 2025
Epigenetic mechanisms of PARP inhibitor resistance in ovarian cancer: A systematic review with bioinformatic analysis of clinically actionable genesMuhammad Habiburrahman, James M Flanagan
Genome Biology|July 3, 2007
An epigenetic role for noncoding RNAs and intragenic DNA methylationJames M Flanagan, Laurence Wild
Australian Veterinary Journal|December 1, 1995
The effects of vaccination of Merino ewes with an attenuated Australian bluetongue virus serotype 23 at different stages of gestationM Flanagan, S J Johnson
Blood|October 1, 1996
Macrophage colony-stimulating factor induces substantial osteoclast generation and bone resorption in human bone marrow culturesU Sarma, A M Flanagan
Cancer Prevention Research (Philadelphia, Pa.)|June 12, 2013
Genome-wide hypomethylation and cancer risk--responseKevin Brennan, James M Flanagan
Pathology|November 8, 2017
A diagnostic approach to bone tumoursAdrienne M Flanagan, Daniel Lindsay
Cell Death and Differentiation|December 18, 2007
BH3 domains define selective inhibitory interactions with BHRF-1 and KSHV BCL-2A M Flanagan, A Letai
British Journal of Cancer|December 15, 2011
Intragenic DNA methylation: implications of this epigenetic mechanism for cancer researchN Shenker, J M Flanagan
Pageof 84